SHANGHAI, June 1 (Reuters) - China stocks eked out gains on
Tuesday, helped by strength in healthcare firms, as investors
cheered Beijing's latest three-child policy after recent data
showed a dramatic decline in births in the world's most populous
** The blue-chip CSI300 index was up 0.2% at
5,341.68, while the Shanghai Composite Index added 0.3%
** Shenzhen's start-up board ChiNext slipped 0.3%,
while Shanghai's tech-focused STAR50 index firmed
** Leading the gains, the CSI300 healthcare index
** Birth- and fertility-related companies advanced as
investors continued to cheer Beijing's major policy support.
** Married Chinese couples may have up to three children,
China announced on Monday. Beijing had scrapped its decades-old
one-child policy in 2016, replacing it with a two-child limit to
try and stave off risks to its economy from a rapidly aging
** Jiangsu Aoyang Health Industry Co Ltd,
Shanghai Aiyingshi, Beingmate Co Ltd,
Changchun High & New Technology Industries Group Inc
and Goldlok Holdings Guangdong Co Ltd climbed
between 5.2% and 10%.
** But analysts and traders expected limited impact from the
policy shift on the market as a whole.
** "The three-child policy could have an impact on China's
long-term economic growth, while its stimulus could be limited
for those who already have two children," Luo Kun, an investment
manager at Chasing Securities' equities investment arm, said.
** Luo said he did not see a major impact on the stock
market, noting gains for related companies could mainly be a
result of short-term speculation.
** China's market regulator fined 15 private tutoring firms
a combined 36.5 million yuan ($5.73 million) for false
advertising and pricing frauds, the official People's Daily
newspaper reported on Tuesday, amid a crackdown on the sector.
(Reporting by Shanghai Newsroom, Editing by Sherry